140 related articles for article (PubMed ID: 3031569)
1. [Mechanism of the vasodilating effect and blood platelet- antiaggregating activity of molsidomine and SIN-1].
Kukovetz WR; Holzmann S
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):260-5. PubMed ID: 3031569
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
Gerzer R; Drummer C; Karrenbrock B; Heim JM
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
Karrenbrock B; Grewe R; Loeschke K; Gerzer R
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of nitrates with regard to vasodilatation and tolerance.
Kukovetz WR; Holzmann S
Z Kardiol; 1986; 75 Suppl 3():8-11. PubMed ID: 2879392
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of nitrate-induced vasodilation and tolerance.
Kukovetz WR; Holzmann S
Z Kardiol; 1983; 72 Suppl 3():14-9. PubMed ID: 6141677
[TBL] [Abstract][Full Text] [Related]
6. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
Bult H; Fret HR; Herman AG
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S120-3. PubMed ID: 2484689
[TBL] [Abstract][Full Text] [Related]
7. Cyclic GMP as the mediator of molsidomine-induced vasodilatation.
Kukovetz WR; Holzmann S
Eur J Pharmacol; 1986 Mar; 122(1):103-9. PubMed ID: 3007172
[TBL] [Abstract][Full Text] [Related]
8. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
Mülsch A; Busse R; Bassenge E
Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of soluble coronary arterial guanylate cyclase by SIN-1.
Schmidt K; Kukovetz WR
Eur J Pharmacol; 1986 Mar; 122(1):75-9. PubMed ID: 2869962
[TBL] [Abstract][Full Text] [Related]
10. Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries.
Kukovetz WR; Holzmann S
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S40-6. PubMed ID: 2484698
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of vasodilation by molsidomine.
Kukovetz WR; Holzmann S
Am Heart J; 1985 Mar; 109(3 Pt 2):637-40. PubMed ID: 2983523
[TBL] [Abstract][Full Text] [Related]
12. [Molsidomine: importance in treatment of circulation disorders].
Kmieć M; Ochmański W
Przegl Lek; 1998; 55(10):532-6. PubMed ID: 10224868
[TBL] [Abstract][Full Text] [Related]
13. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis.
Darius H; Ahland B; Rücker W; Klaus W; Peskar BA; Schrör K
J Cardiovasc Pharmacol; 1984; 6(1):115-21. PubMed ID: 6199592
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of vasodilation by nitrates: role of cyclic GMP.
Kukovetz WR; Holzmann S; Romanin C
Cardiology; 1987; 74 Suppl 1():12-9. PubMed ID: 2886220
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
Gerzer R; Karrenbrock B; Siess W; Heim JM
Thromb Res; 1988 Oct; 52(1):11-21. PubMed ID: 2904706
[TBL] [Abstract][Full Text] [Related]
16. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
17. [SIN-1 interactions with the generation of cyclic nucleotides and arachidonate oxide metabolites in the uterine muscle].
Bourgoin S; Leiber D; Harbon S
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):255-9. PubMed ID: 2882463
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the action of nitric oxide prodrugs by pyocyanin: mechanistic studies.
Hussain AS; Bozinovski J; Maurice DH; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1997 May; 75(5):398-406. PubMed ID: 9250373
[TBL] [Abstract][Full Text] [Related]
20. Effect of in vitro organic nitrate tolerance on relaxation, cyclic GMP accumulation, and guanylate cyclase activation by glyceryl trinitrate and the enantiomers of isoidide dinitrate.
Bennett BM; Schröder H; Hayward LD; Waldman SA; Murad F
Circ Res; 1988 Oct; 63(4):693-701. PubMed ID: 2901920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
